Dr. Elvis Awuni
Focus & expertise
Specializations
Publications ORCID 0000-0001-6719-7010 →
2026
Unveiling nicotiflorin analogs with improved oral drug-like metrics as candidates for the development of dengue virus NS2B-NS3 protease inhibitors: An in silico study
journal article
2026
Combined antibacterial effects of turmeric and cinnamon ethanolic extracts with ampicillin against resistant-microbial strains: in vitro and molecular docking approaches
journal article
2025
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems
journal article
2025
Evaluating the MreB-Binding Prospects of Proposed Antibacterial Peptides through Molecular Modeling and Simulations
journal article
2025
Identification of lead small molecules for the design and development of potent severe acute respiratory syndrome coronavirus 2 main protease inhibitors
journal article
2024
Proposing lead compounds for the development of SARS-CoV-2 receptor-binding inhibitors
journal article
2022
Modeling the MreB-CbtA Interaction to Facilitate the Prediction and Design of Candidate Antibacterial Peptides
journal article
2020
Status of Targeting MreB for the Development of Antibiotics
journal article
2019
Effect of A22 on the Conformation of Bacterial Actin MreB
journal article
2018
Proposing drug fragments for dengue virus NS5 protein
journal article